As per the report, the interventional cardiology devices market size was US$ 19.1 billion in 2020. It is projected to grow US$ 46.72 billion by 2030 at a CAGR of 9.4% in the forecast period.
Download the FREE Sample Report (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1475
Market Overview
A recent study by Precedence Research on the interventional cardiology devices market offers a forecast for 2021 and 2030. The study analyzes crucial trends that are currently determining the growth of the interventional cardiology devices market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of interventional cardiology devices. The study also provides the dynamics that are responsible for influencing the future status of this market over the forecast period.
A detailed assessment of the interventional cardiology devices market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the interventional cardiology devices market along with their product portfolio enhances the reliability of this comprehensive research study.
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
Key Points
- Primary Research
- Secondary Research
- Market Size Estimation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends and Assessment
- Market Factor Analysis
- Porter’s Five Forces Analysis
- Bargaining Power Of Suppliers
- Bargaining Power Of Buyers
- Threat Of New Entrants
- Threat Of Substitutes
- Intensity Of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
Research Methodology
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, the structure of the market participants and industry's competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
Industry participants involved in this research study include:
- CEOs, VPs, market intelligence managers
- Procuring and national sales managers technical personnel, distributors and resellers
- Research analysts and key opinion leaders from various domains
Competition Landscape
In the final section of the report on the global interventional cardiology devices market, a 'dashboard view' of the companies has been provided to compare the current market scenario and the contribution of companies to the global interventional cardiology devices market. Moreover, the report is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to segments of the global market. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and success in the interventional cardiology devices marketplace.
Some of the prominent players in the global interventional cardiology devices market include:
- Boston Scientific Corporation
- Medtronic
- Edward Lifesciences Corporation
- Abbott
- BIOTRONIK SE & Co. KG
- iVascular
- Terumo Corporation
- B. BarunMelsungen
- Biosensors International Group
- Cardinal Health
Market Segmentation
Segments of the global interventional cardiology devices market have been analyzed in terms of their market share to understand an individual segment’s relative contribution to market growth. This detailed level of information is important for identifying key trends in the global interventional cardiology devices market.
Market Segments as below:
By Product
- Angioplasty Balloons
- Angioplasty Stents
- Angioplasty Catheters
- Endovascular Aneurysm Repair Stent Grafts
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Accessories
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- MEA
- Rest of the World
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Interventional Cardiology Devices Market
5.1. COVID-19 Landscape: Interventional Cardiology Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Interventional Cardiology Devices Market, By Product
8.1. Interventional Cardiology Devices Market, by Product Type, 2021-2030
8.1.1. Angioplasty Balloons
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Angioplasty Stents
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Angioplasty Catheters
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Endovascular Aneurysm Repair Stent Grafts
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Inferior Vena Cava (IVC) Filters
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Plaque Modification Devices
8.1.6.1. Market Revenue and Forecast (2019-2030)
8.1.7. Hemodynamic Flow Alteration Devices
8.1.7.1. Market Revenue and Forecast (2019-2030)
8.1.8. Accessories
8.1.8.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Interventional Cardiology Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2019-2030)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.3. France
9.2.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.4. Rest of Europe
9.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Product (2019-2030)
Chapter 10. Company Profiles
10.1. Boston Scientific Corporation
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Edward Lifesciences Corporation
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Abbott
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. BIOTRONIK SE & Co. KG
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. iVascular
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Terumo Corporation
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. B. BarunMelsungen
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Biosensors International Group
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Cardinal Health
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Why Buy this Report?
The purpose of Precedence Research's interventional cardiology devices market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1475
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments